Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Man...

FDA Recall #D-0217-2026 — Class II — October 24, 2025

Recall #D-0217-2026 Date: October 24, 2025 Classification: Class II Status: Ongoing

Product Description

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.

Reason for Recall

Failed stability specifications: Out of specification for hardness test

Recalling Firm

Cipla USA, Inc. — Warren, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1180 boxes

Distribution

Nationwide in the USA

Code Information

lot# NB240315, exp 12/31/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated